RE-BVS – Piemonte Repository

Sfoglia per AUTORE
RIGOLIN GM
Collezione AO Ordine Mauriziano

Items : 4

High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study. in Haematologica / Haematologica. 2023 Aug 1;108(8):2091-2100. doi: 10.3324/haematol.2022.282116.

2023
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano

Foà R; Fazi P; Vignetti M; Piciocchi A; Cuneo A; Del Giudice I; Guarini A; De Propris MS; Nanni M; De Novi LA; Neri A; Albano F; Vitale C; Visentin A; Mattiello V; Pietrasanta D; Molinari MC; Giordano A; Gottardi D; Liberati AM; Patrizi VB; Deodato M; Galieni P; Arcari A; Musuraca G; Levato L; Tani M; Marchetti M; Rigolin GM; et alii...

Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report. in Hematological oncology / Hematol Oncol. 2021 Oct;39(4):570-574. doi: 10.1002/hon.2899. Epub 2021 Jul 13.

2021
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano

Chiarenza A; Orsucci L; Levato L; Gottardi D; Derenzini E; Gattei V; Sanna A; Gozzetti A; Baratè C; Olivieri J; Murru R; Gentile M; Leone M; Stefoni V; Malerba L; Ibatici A; Tisi MC; Marasca R; Chiurazzi F; Del Poeta G; Varettoni M; Farina L; Giordano A; Marchetti M; De Paoli L; Foglietta M; Re F; Ferrari A; Pietrasanta D; et alii...

Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study. in Cancers / Cancers (Basel). 2021 Dec 31;14(1):207. doi: 10.3390/cancers14010207.

2021
AOU Alessandria
AO Ordine Mauriziano

Piciocchi A; Guarini A; Rigolin GM; Neri A; Fazi P; Nanni M; Raponi S; Della Starza I; De Propris MS; Del Giudice I; Ruocco V; Murru R; Laurenti L; Varettoni M; Ibatici A; Chiarenza A; Gentile M; Molinari A; Gozzetti A; Zinzani PL; Musuraca G; Gottardi D; Tani M; Re F; Liberati AM; Orsucci L; Ilariucci F; Di Renzo N; Stelitano C; et alii...

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia. in Blood / Blood. 2015 Oct 15;126(16):1921-4. doi: 10.1182/blood-2015-05-647925. Epub 2015 Aug 14.

2015
AO Ordine Mauriziano

Rossi D; Terzi-di-Bergamo L; De Paoli L; Cerri M; Ghilardi G; Chiarenza A; Bulian P; Visco C; Mauro FR; Morabito F; Cortelezzi A; Zaja F; Forconi F; Laurenti L; Del Giudice I; Gentile M; Vincelli I; Motta M; Coscia M; Rigolin GM; Tedeschi A; Neri A; Marasca R; Perbellini O; Moreno C; Del Poeta G; Massaia M; Zinzani PL; Montillo M; et alii...